{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:25:41Z","timestamp":1772166341030,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thyroid Res"],"DOI":"10.1186\/s13044-025-00238-7","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T08:26:55Z","timestamp":1747211215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparing antithyroid drugs vs. radioactive iodine in paediatric Graves\u2019 disease: literature review"],"prefix":"10.1186","volume":"18","author":[{"given":"Akshat","family":"Sinha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reuben","family":"Oza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon Karamveer","family":"Sangha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arshia","family":"Akhavan-Mofrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvin","family":"Suddhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"238_CR1","doi-asserted-by":"crossref","unstructured":"Lee HS, Hwang JS. The treatment of Graves\u2019 disease in children and adolescents. Ann Pediatr Endocrinol Metab. 2014 Sep [cited 2022 Feb 2];19(3):126. Available from: \/pmc\/articles\/PMC4208256\/","DOI":"10.6065\/apem.2014.19.3.122"},{"key":"238_CR2","unstructured":"Pokhrel B, Bhusal K. Graves Disease. StatPearls. 2021 Jul 21 [cited 2022 Feb 2]; Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK448195\/"},{"key":"238_CR3","doi-asserted-by":"crossref","unstructured":"Pearce EN. Diagnosis and management of thyrotoxicosis. BMJ Br Med J. 2006 Jun 10 [cited 2022 Feb 2];332(7554):1373. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC1476727\/","DOI":"10.1136\/bmj.332.7554.1369"},{"key":"238_CR4","unstructured":"National Institute for Health and Care Excellence. Thyroid disease: assessment and management. NICE guidelines NG145. London: National Institute for Health and Care Excellence. 2019 [cited 2022 Feb 2]. Available from: https:\/\/www.nice.org.uk\/guidance\/ng145"},{"key":"238_CR5","unstructured":"Abdi H, Amouzegar A, Azizi F, Antithyroid Drugs. Iran J, Pharm Res, IJPR. 2019 Sep 1 [cited 2022 Feb 2];18(Suppl1):12. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7393052\/"},{"key":"238_CR6","unstructured":"Mumtaz M, Lin LS, Hui KC, Khir ASM. Radioiodine I-131 For The Therapy Of Graves\u2019 Disease. Malays J Med Sci. 2009 [cited 2022 Feb 2];16(1):33. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3336179\/"},{"key":"238_CR7","doi-asserted-by":"crossref","unstructured":"Sch\u00fcssler-Fiorenza CM, Bruns CM, Chen H. The surgical management of Graves\u2019 disease. J Surg Res. 2006 Jun 15 [cited 2022 Feb 2];133(2):207\u201314. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/16458922\/#:~:text=Materials and methods%3A The three, radioactive iodine therapy%2\u00a0C and surgery.","DOI":"10.1016\/j.jss.2005.12.014"},{"key":"238_CR8","doi-asserted-by":"crossref","unstructured":"Bauer AJ. Approach to the Pediatric Patient with Graves\u2019 Disease: When Is Definitive Therapy Warranted? J Clin Endocrinol Metab. 2011 Mar 1 [cited 2022 Feb 2];96(3):580\u20138 Available from: https:\/\/academic.oup.com\/jcem\/article\/96\/3\/580\/2596398","DOI":"10.1210\/jc.2010-0898"},{"key":"238_CR9","doi-asserted-by":"crossref","unstructured":"Cooper DS. Hyperthyroidism. Lancet. 2003 Aug 9 [cited 2022 Feb 2];362(9382):459\u201368. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0140673603140731","DOI":"10.1016\/S0140-6736(03)14073-1"},{"key":"238_CR10","doi-asserted-by":"crossref","unstructured":"Lee JA, Grumbach MM, Clark OH. The Optimal Treatment for Pediatric Graves\u2019 Disease Is Surgery. J Clin Endocrinol Metab. 2007 Mar 1 [cited 2022 Feb 2];92(3):801\u20133. Available from: https:\/\/academic.oup.com\/jcem\/article\/92\/3\/801\/2596860","DOI":"10.1210\/jc.2006-1238"},{"key":"238_CR11","doi-asserted-by":"crossref","unstructured":"Rivkees SA. Pediatric Graves\u2019 Disease: Controversies in Management. Horm Res Paediatr. 2010 Nov [cited 2022 Feb 2];74(5):305\u201311. Available from: https:\/\/www.karger.com\/Article\/FullText\/320028","DOI":"10.1159\/000320028"},{"key":"238_CR12","doi-asserted-by":"publisher","unstructured":"Brown D. A Review of the PubMed PICO Tool: Using Evidence-Based Practice in Health Education. Health Promot Pract. 2020 Jul 21 [cited 2022 Feb 16];21(4):496\u20138. Available from: https:\/\/journals.sagepub.com\/doi\/https:\/\/doi.org\/10.1177\/1524839919893361","DOI":"10.1177\/1524839919893361"},{"key":"238_CR13","doi-asserted-by":"crossref","unstructured":"Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G et al. AGREE II: Advancing guideline development, reporting and evaluation in health care. CMAJ. 2010 Dec 14 [cited 2022 Feb 2];182(18). Available from: https:\/\/www.agreetrust.org\/agree-ii\/","DOI":"10.1503\/cmaj.090449"},{"key":"238_CR14","doi-asserted-by":"crossref","unstructured":"Hoffmann-E\u00dfer W, Siering U, Neugebauer EAM, Brockhaus AC, Lampert U, Eikermann M. Guideline appraisal with AGREE II: Systematic review of the current evidence on how users handle the 2 overall assessments. PLoS One. 2017 Mar 30 [cited 2022 Feb 2];12(3). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5373625\/","DOI":"10.1371\/journal.pone.0174831"},{"key":"238_CR15","unstructured":"National Institute for Health and Care Excellence. Thyroid disease: assessment and management. NICE guidelines NG145, History, Final Scope. London: National Institute for Health and Care Excellence. 2019 [cited 2022 Feb 2]. Available from: https:\/\/www.nice.org.uk\/guidance\/ng145\/documents\/final-scope"},{"key":"238_CR16","unstructured":"National Institute for Health and Care Excellence. Thyroid disease: assessment and management. NICE guidelines NG145, History, Stakeholder List. London: National Institute for Health and Care Excellence. 2019 [cited 2022 Feb 2]. Available from: https:\/\/www.nice.org.uk\/guidance\/ng145\/documents\/stakeholder-list-3"},{"key":"238_CR17","unstructured":"National Institute for Health and Care Excellence. Thyroid disease: assessment and management. NICE guidelines NG145, History, Committee Member List. London: National Institute for Health and Care Excellence. 2019 [cited 2022 Feb 2]. Available from: https:\/\/www.nice.org.uk\/guidance\/ng145\/documents\/committee-member-list"},{"key":"238_CR18","unstructured":"National Institute for Health and Care Excellence. Thyroid disease: assessment and management. NICE guidelines NG145, Evidence, Methods. London: National Institute for Health and Care Excellence. 2019 [cited 2022 Feb 2]. Available from: https:\/\/www.nice.org.uk\/guidance\/ng145\/evidence\/methods-pdf-6967432045"},{"key":"238_CR19","unstructured":"National Institute for Health and Care Excellence. Thyroid disease: assessment and management. NICE guidelines NG145, Tools and Resources, Visual Summary. London: National Institute for Health and Care Excellence. 2019 [cited 2022 Feb 2]. Available from: https:\/\/www.nice.org.uk\/guidance\/ng145\/resources\/visual-summary-pdf-6965793901"},{"key":"238_CR20","unstructured":"National Institute for Health and Care Excellence. Thyroid disease: assessment and management. NICE guidelines NG145, Evidence, Cost Consequence Analysis. London: National Institute for Health and Care Excellence. 2019 [cited 2022 Feb 2]. Available from: https:\/\/www.nice.org.uk\/guidance\/ng145\/evidence\/costconsequenceanalysis-pdf-6967432046"},{"key":"238_CR21","unstructured":"AMSTAR -. Assessing the Methodological Quality of Systematic Reviews. [cited 2022 Feb 4]. Available from: https:\/\/amstar.ca\/Amstar_Checklist.php"},{"key":"238_CR22","doi-asserted-by":"crossref","unstructured":"Akashi H, Ishizuka A, Lee S, Irie M, Oketani H, Akashi R. The role of the G20 economies in global health. Glob Heal Med. 2019 Oct 31 [cited 2022 Feb 4];1(1):15. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7731051\/","DOI":"10.35772\/ghm.2019.01008"},{"key":"238_CR23","unstructured":"CASP CHECKLISTS - CASP -. Critical Appraisal Skills Programme. [cited 2022 Feb 4]. Available from: https:\/\/casp-uk.net\/casp-tools-checklists\/"},{"key":"238_CR24","doi-asserted-by":"crossref","unstructured":"Lutterman SL, Zwaveling-Soonawala N, Verberne HJ, Verburg FA, Van Trotsenburg ASP, Mooij CF. The Efficacy and Short- and Long-Term Side Effects of Radioactive Iodine Treatment in Pediatric Graves\u2019 Disease: A Systematic Review. Eur Thyroid J. 2021 Jul [cited 2022 Feb 4];10(5):353\u201363. Available from: https:\/\/www.karger.com\/Article\/FullText\/517174","DOI":"10.1159\/000517174"},{"key":"238_CR25","doi-asserted-by":"crossref","unstructured":"Van Lieshout JM, Mooij CF, van Trotsenburg ASP, Zwaveling-Soonawala N. Methimazole-induced remission rates in pediatric Graves\u2019 disease: a systematic review. Eur J Endocrinol. 2021 Jul 7 [cited 2022 Feb 4];185(2):219\u201329. Available from: https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/185\/2\/EJE-21-0077.xml","DOI":"10.1530\/EJE-21-0077"},{"key":"238_CR26","doi-asserted-by":"crossref","unstructured":"Namwongprom S, Dejkhamron P, Unachak K. Success rate of radioactive iodine treatment for children and adolescent with hyperthyroidism. J Endocrinol Invest. 2021 Jun 24 [cited 2022 Feb 4];44(3):541\u20135. Available from: https:\/\/link.springer.com\/article\/10.1007%2Fs40618-020-01339-w","DOI":"10.1007\/s40618-020-01339-w"},{"key":"238_CR27","doi-asserted-by":"crossref","unstructured":"Lee HG, Yang EM, Kim CJ. Efficacy and adverse events related to the initial dose of methimazole in children and adolescents with Graves\u2019 disease. Ann Pediatr Endocrinol Metab. 2021 Sep 30 [cited 2022 Feb 4];26(3):199\u2013204. Available from: https:\/\/e-apem.org\/journal\/view.php?doi=10.6065\/apem.2142046.023","DOI":"10.6065\/apem.2142046.023"},{"key":"238_CR28","doi-asserted-by":"crossref","unstructured":"Song A, Kim SJ, Kim MS, Kim J, Kim I, Bae GY et al. Long-Term Antithyroid Drug Treatment of Graves\u2019 Disease in Children and Adolescents: A 20-Year Single-Center Experience. Front Endocrinol (Lausanne). 2021 Jun 14 [cited 2022 Feb 4];12. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8236938\/#B19","DOI":"10.3389\/fendo.2021.687834"},{"key":"238_CR29","doi-asserted-by":"crossref","unstructured":"Mizokami T, Hamada K, Maruta T, Higashi K, Tajiri J. Long-Term Outcomes of Radioiodine Therapy for Juvenile Graves Disease with Emphasis on Subsequently Detected Thyroid Nodules: A Single Institution Experience from Japan. Endocr Pract. 2020 Jul 1 [cited 2022 Feb 4];26(7):729\u201337. Available from: https:\/\/www.endocrinepractice.org\/article\/S1530-891X(20)36011-0\/fulltext","DOI":"10.4158\/EP-2019-0468"},{"key":"238_CR30","unstructured":"Ehrhart MD, Guthrie IR, Bucheli JR, Burge MR. What is the Role of Race and Ethnicity in the Development Of Thionamide-Induced Neutropenia? J Endocrinol Thyroid Res. 2018 Feb 28 [cited 2022 Feb 4];3(1). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6394871\/"},{"key":"238_CR31","doi-asserted-by":"crossref","unstructured":"Clarke M, Williamson PR. Core outcome sets and systematic reviews. Syst Rev. 2016 Jan 20 [cited 2022 Feb 16];5(1):1\u20134. Available from: https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-016- 0188-6.","DOI":"10.1186\/s13643-016-0188-6"},{"key":"238_CR32","doi-asserted-by":"crossref","unstructured":"Glaser NS, Styne DM, Group for the O of PE of NCCGDS. Predicting the Likelihood of Remission in Children With Graves\u2019 Disease: A Prospective, Multicenter Study. Pediatrics. 2008 Mar [cited 2022 Feb 4];121(3):e481\u20138. Available from: https:\/\/publications.aap.org\/pediatrics\/article-abstract\/121\/3\/e481\/72820\/Predictingthe- Likelihood-of-Remission-in-Children?redirectedFrom\u2009=\u2009fulltext.","DOI":"10.1542\/peds.2007-1535"},{"key":"238_CR33","doi-asserted-by":"crossref","unstructured":"Karmisholt J, Andersen SL, Bulow-Pedersen I, Carl\u00e9 A, Krejbjerg A, Nygaard B. Predictors of Initial and Sustained Remission in Patients Treated with Antithyroid Drugs for Graves\u2019 Hyperthyroidism: The RISG Study. J Thyroid Res. 2019 Jan 3 [cited 2022 Feb 16];2019. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6335719\/","DOI":"10.1155\/2019\/5945178"},{"key":"238_CR34","unstructured":"Young ET, Steel NR, Taylor JJ, Stephenson AM, Stratton A, Holcombe M et al. Prediction of Remission after Antithyroid Drug Treatment in Graves\u2019 Disease. QJM An Int J Med. 1988 Feb 1 [cited 2022 Feb 16];66(2):175\u201389. Available from: https:\/\/academic.oup.com\/qjmed\/articleabstract\/66\/2\/175\/1593890?redirectedFrom=fulltext"},{"key":"238_CR35","doi-asserted-by":"crossref","unstructured":"Zaat AS, Derikx JPM, Zwaveling-Soonawala N, Van Trotsenburg ASP, Mooij CF. Thyroidectomy in Pediatric Patients with Graves\u2019 Disease: A Systematic Review of Postoperative Morbidity. Eur Thyroid J. 2021 Mar [cited 2022 Feb 4];10(1):39\u201351. Available from: https:\/\/etj.bioscientifica.com\/view\/journals\/etj\/10\/1\/ETJ511345.xml","DOI":"10.1159\/000511345"},{"key":"238_CR36","unstructured":"Fortuny JV, Guigard S, Karenovics W, Triponez F. Surgery of the thyroid: recent developments and perspective. Swiss Med Wkly 2015 31. 2015 Jul 26 [cited 2022 Feb 4];145(31). Available from: https:\/\/smw.ch\/article\/doi\/smw.2015.14144"},{"key":"238_CR37","unstructured":"Chadwick D, Bch BM, Kinsman R, Walton P, Frcp M. The British Association of Endocrine & Thyroid Surgeons Prepared by on behalf of The British Association of Endocrine & Thyroid Surgeons 2017 [cited 2022 Feb 4]; Available from: https:\/\/www.baets.org.uk\/wp-content\/uploads\/BAETS-Audit-National-Report-2017.pdf"},{"key":"238_CR38","doi-asserted-by":"crossref","unstructured":"Sosa JA, Bowman HM, Tielsch JM, Powe NR, Gordon TA, Udelsman R. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg. 1998 Sep [cited 2022 Feb 4];228(3):330. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC1191485\/","DOI":"10.1097\/00000658-199809000-00005"},{"key":"238_CR39","doi-asserted-by":"crossref","unstructured":"Dent J, Brun J, Fendrick AM, Fennerty MB, Janssens J, Kahrilas PJ et al. An evidence-based appraisal of reflux disease management \u2014 the Genval Workshop Report. Gut. 1998 Apr [cited 2022 Feb 4];44(suppl 2): S1\u201316. Available from: https:\/\/gut.bmj.com\/content\/44\/suppl_2\/S1","DOI":"10.1136\/gut.44.2008.S1"},{"issue":"1","key":"238_CR40","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3390\/cancers17010107","volume":"17","author":"EM Persons","year":"2025","unstructured":"Persons EM, Hussein MH, Herrera M, Pinion D, Webster A, Pineda E, et al. The impact of radioactive iodine on outcomes among pediatric and adolescent thyroid cancer patients: A SEER database analysis. Cancers. 2025;17(1):107. https:\/\/doi.org\/10.3390\/cancers17010107.","journal-title":"Cancers"},{"issue":"8","key":"238_CR41","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1089\/thy.2019.0560","volume":"30","author":"M Nies","year":"2020","unstructured":"Nies M, Cantineau AEP, Arts EGJM, van den Berg MH, van Leeuwen FE, Muller Kobold AC, et al. Long-Term effects of radioiodine treatment on female fertility in survivors of childhood differentiated thyroid carcinoma. Thyroid. 2020;30(8):1169\u201376. Epub 2020 Apr 9. PMID: 32079487.","journal-title":"Thyroid"},{"issue":"2","key":"238_CR42","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000277140","volume":"73","author":"SA Rivkees","year":"2010","unstructured":"Rivkees SA, Stephenson K. Radioiodine in the management of pediatric graves\u2019 disease: Evidence-based experience and perspectives. Horm Res Paediatr. 2010;73(2):81\u20139.","journal-title":"Horm Res Paediatr"},{"issue":"3","key":"238_CR43","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1210\/jc.2010-0898","volume":"96","author":"AJ Bauer","year":"2011","unstructured":"Bauer AJ. Approach to the pediatric patient with graves\u2019 disease: when is definitive therapy warranted? J Clin Endocrinol Metab. 2011;96(3):580\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"238_CR44","doi-asserted-by":"publisher","first-page":"126","DOI":"10.6065\/apem.2014.19.3.122","volume":"19","author":"HS Lee","year":"2014","unstructured":"Lee HS, Hwang JS. The treatment of graves\u2019 disease in children and adolescents. Ann Pediatr Endocrinol Metab. 2014;19(3):126\u201330.","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"8","key":"238_CR45","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1023\/B:EJEP.0000036568.02655.f8","volume":"19","author":"VL Kristman","year":"2004","unstructured":"Kristman VL, Manno M, C\u00f4t\u00e9 P. Loss to follow-up in cohort studies: how much is too much? Eur J Epidemiol. 2004;19(8):751\u201360.","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"238_CR46","doi-asserted-by":"publisher","first-page":"CD010094","DOI":"10.1002\/14651858.CD010094.pub2","volume":"2","author":"C Ma","year":"2016","unstructured":"Ma C, Xie J, Wang H, Li J, Chen S. Radioiodine therapy versus antithyroid medications for graves\u2019 disease. Cochrane Database Syst Rev. 2016;2(2):CD010094. https:\/\/doi.org\/10.1002\/14651858.CD010094.pub2. PMID: 26891370; PMCID: PMC10517434.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"238_CR47","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000511345","volume":"10","author":"AS Zaat","year":"2021","unstructured":"Zaat AS, Derikx JPM, Zwaveling-Soonawala N, van Trotsenburg ASP, Mooij CF. Thyroidectomy in pediatric patients with graves\u2019 disease: A systematic review of postoperative morbidity. Eur Thyroid J. 2021;10(1):39\u201351. https:\/\/doi.org\/10.1159\/000511345. Epub 2020 Nov 17. PMID: 33777818; PMCID: PMC7983567.","journal-title":"Eur Thyroid J"}],"container-title":["Thyroid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13044-025-00238-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13044-025-00238-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13044-025-00238-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T08:27:16Z","timestamp":1747211236000},"score":1,"resource":{"primary":{"URL":"https:\/\/thyroidresearchjournal.biomedcentral.com\/articles\/10.1186\/s13044-025-00238-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["238"],"URL":"https:\/\/doi.org\/10.1186\/s13044-025-00238-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4513276\/v1","asserted-by":"object"}]},"ISSN":["1756-6614"],"issn-type":[{"value":"1756-6614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"1 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}